Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-664P, also known as “RNA, U6 small nuclear 664, pseudogene,” is a pseudogene related to the U6 small nuclear RNA (snRNA) gene family. U6 snRNAs are highly conserved, non-coding RNAs involved in the splicing of pre-mRNA as essential components of the spliceosome. Pseudogenes like RNU6-664P may arise via genomic duplication or retrotransposition, but they typically lack a functional role and are not expressed as active RNAs or proteins. These pseudogenes are not considered protein targets, enzymes, receptors, or therapeutic agents. "FZD5" is the abbreviation for “Frizzled class receptor 5,” an unrelated G protein-coupled receptor involved in Wnt signaling pathways. There is no molecular or functional relationship between FZD5 and RNU6-664P—this alias appears to be an error. U6 small nuclear RNA (U6 snRNA) is a functional RNA component of the spliceosome. However, RNU6-664P is a pseudogene and does not code for a functional RNA. The main issues are that RNU6-664P is a pseudogene, not an active therapeutic target; the alias “FZD5” is misapplied; and there are no known drugs, mechanisms of action, or biomarker roles for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 664, pseudogene (RNU6-664P).